Resources » Resources Search » MPP/Havard T.H. Chan School of Public Health: Projected savings through public health voluntary licences of HIV drugs negotiated by the MPP

MPP/Havard T.H. Chan School of Public Health: Projected savings through public health voluntary licences of HIV drugs negotiated by the MPP

Harvard T.H. Chan School of Public Health/MPP study in peer-reviewed journal PLOS ONE in May 2017 estimating that savings of its licensing agreements for antiretrovirals (ARVs) to treat HIV in low- and middle-income countries could reach US$ 2.3 billion by 2028.

Access the study

This website uses cookies to ensure you get the best experience on our website. Learn More